Migraine Surgery, Part II


David Branch, MD, of Bangor Plastic and Hand Surgery, discusses issues including the pathophysiology of migraines and drugs used to treat migraines.

In the second of a five-part series on surgical treatment of migraines, David Branch, MD, of Bangor Plastic and Hand Surgery discusses issues such as the pathophyisology of migraines and some of the drugs used to treat migraines.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.